Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Cardiovascular Drugs
Tag: Cardiovascular Drugs
Biotechnology
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
BioChannel
-
October 7, 2019
Biotechnology
Bayer to Acquire BlueRock Therapeutics for Up-to-$600M, with Cell Therapy Pipeline...
BioChannel
-
August 8, 2019
Biotechnology
Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic...
BioChannel
-
July 5, 2019
Biotechnology
Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic...
BioChannel
-
July 5, 2019
Stay connected
52,371
Followers
Follow
14,700
Subscribers
Subscribe
Recent posts
Study provides long-term look at ways to control wildfire in sagebrush steppe ecosystem
BioChannel
-
May 16, 2022
Psychotropic Compound Synthesized from Rainforest Tree
BioChannel
-
May 16, 2022
CRISPR Can Help The Switch To Sustainable Cosmetics
BioChannel
-
May 16, 2022
Random article
Study provides long-term look at ways to control wildfire in sagebrush...
Psychotropic Compound Synthesized from Rainforest Tree
CRISPR Can Help The Switch To Sustainable Cosmetics
Vir Biotechnology (VIR) Stock: $125 Price Target And Buy Rating –...
Edit with Live CSS
